Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.61% | -62.85% | -71.79% | -5.67% | 41.13% |
| Total Depreciation and Amortization | 5.44% | 4.89% | 7.18% | 7.17% | 7.50% |
| Total Amortization of Deferred Charges | 100.00% | 50.00% | 0.00% | 344.44% | -- |
| Total Other Non-Cash Items | 4.54% | 59.72% | 107.05% | 50.51% | -7.84% |
| Change in Net Operating Assets | -77.43% | -32.51% | 43.96% | 118.46% | 296.75% |
| Cash from Operations | -2,943.85% | -268.17% | -57.07% | 56.77% | 97.11% |
| Capital Expenditure | -3.09% | -63.14% | -158.21% | -103.04% | -47.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -292.11% | -343.07% | -417.54% | -305.48% | -131.93% |
| Cash from Investing | -18.68% | -78.97% | -173.96% | -149.27% | -111.27% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -17.18% | -13.84% | -10.36% | -9.85% | -9.32% |
| Issuance of Common Stock | -- | -- | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.91% | 91.45% | 89.97% | -3.24% | -1,087.14% |
| Cash from Financing | -111.54% | -111.13% | -110.97% | -4.81% | 1,216.11% |
| Foreign Exchange rate Adjustments | -4,892.45% | -764.13% | 283.73% | 280.25% | 243.24% |
| Miscellaneous Cash Flow Adjustments | -100.00% | 20.00% | -- | 320.00% | 200.00% |
| Net Change in Cash | -184.38% | -179.57% | -175.26% | 415.03% | 211.80% |